- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
3
0 new
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
3 companies
PharmaResearch
Market Cap: ₩6.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩680,000.00
7D
22.5%
1Y
289.5%
ABL Bio
Market Cap: ₩4.1t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩77,500.00
7D
8.1%
1Y
150.0%
LigaChem Biosciences
Market Cap: ₩5.4t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩149,500.00
7D
10.2%
1Y
58.4%